NurExone Biologic Inc.
NRXBF
$0.40
$0.000.40%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.37% | 117.50% | -19.95% | 108.84% | -16.00% |
| Total Receivables | 71.91% | -27.05% | 45.24% | -37.78% | 6.30% |
| Inventory | -- | -- | -- | 0.00% | 0.00% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -84.23% | 580.49% | 0.00% | 0.00% | 0.00% |
| Total Current Assets | -34.37% | 126.96% | -41.32% | 43.18% | -16.52% |
|
|
|||||
| Total Current Assets | -34.37% | 126.96% | -41.32% | 43.18% | -16.52% |
| Net Property, Plant & Equipment | -4.86% | -2.04% | -3.18% | 17.40% | -3.84% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | -- | -- | -- |
| Total Assets | -22.92% | 54.31% | -7.61% | 33.83% | -12.33% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -34.20% | 88.52% | 11.25% | 75.94% | -44.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 18.77% | -47.38% | -26.84% | 85.25% | 542.11% |
| Total Other Current Liabilities | 18.77% | -47.38% | -26.84% | 85.25% | 542.11% |
| Total Current Liabilities | -22.75% | 14.73% | -14.40% | 82.10% | 38.94% |
|
|
|||||
| Total Current Liabilities | -22.75% | 14.73% | -14.40% | 82.10% | 38.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.86% | -11.39% | -13.19% | 193.55% | 0.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.67% | 7.26% | 5.98% | -2.50% | -4.38% |
| Total Liabilities | -13.58% | 11.44% | -10.74% | 61.65% | 21.18% |
|
|
|||||
| Common Stock & APIC | 2.65% | 9.52% | 4.70% | 11.46% | 4.86% |
| Retained Earnings | -6.93% | -5.79% | -6.48% | -8.88% | -8.79% |
| Treasury Stock & Other | 14.84% | 24.78% | 22.81% | -16.54% | 20.50% |
| Total Common Equity | -27.41% | 89.29% | -4.90% | 16.41% | -25.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -27.41% | 89.29% | -4.90% | 16.41% | -25.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -27.41% | 89.29% | -4.90% | 16.41% | -25.27% |
|
|
|||||